'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Reddys Laboratories has increased 6.58% to Rs 7236.8 crore compared to quarter ended Dec 2022.  Sales of Pharmaceutical Services segment has gone up 2.68% to Rs 1,058.00 crore (accounting for 14.12% of total sales).  Sales of Global Generics segment has gone up 6.49% to Rs 6,312.40 crore (accounting for 84.26% of total sales).  Sales of Others segment has gone up 73.08% to Rs 121.50 crore (accounting for 1.62% of total sales).  Inter-segment sales rose Rs 238.40 crore to Rs 255.10 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 5.26% to Rs 4,220.70 crore.  PBIT of Pharmaceutical Services segment rose 63.27% to Rs 230.70 crore (accounting for 5.47% of total PBIT).  PBIT of Global Generics segment rose 2.15% to Rs 3,907.70 crore (accounting for 92.58% of total PBIT). &...

• 

  (20-Apr-2025)

  Just Dial

  Net up 36% on 7% increase in sales
• 

  (20-Apr-2025)

  HDFC Bank

  Gaining traction
• 

  (20-Apr-2025)

  ICICI Bank

  Continues strong performance
• 

  (19-Apr-2025)

  Yes Bank

  Asset quality and margins improves